MGMT and central nervous system cancer: Kaplan-Meier survival of MGMT met group in all glioma cases was 11 months (range 5.9 to 16.13 months) while for MGMT unmet group was 13 months (range 6.5 to 19.5 months) with no significant difference between groups (P > 0.05).